Sanofi’s Sarclisa approved by MHRA as UK’s first anti-cancer treatment given via on-body injector
It is the first anticancer treatment in the UK and globally to be administered this way and a first in multiple myeloma
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Takeda’s new study data for oveporexton shows improvements in narcolepsy type 1
The phase 3 results show improvements in daily function, cognition and nighttime sleep
Lilly to acquire LimmaTech Biologics and Vaccine Company in deals totalling $2.33bn
The acquisitions reinforce the company’s commitment to reduce the long-term burden of serious disease
Sanofi’s Sarclisa approved by MHRA as UK’s first anti-cancer treatment given via on-body injector
It is the first anticancer treatment in the UK and globally to be administered this way and a first in multiple myeloma
EMA celebrates diversity and inclusion in science and healthcare
The EU body underlines its commitment to diverse perspectives in medicines regulation
PMEA welcome Simon Bates as new Chair of the judging panel
Roche and Alnylam share their experiences entering the PMEAs
Latest content
Pfizer appoints Cecile Guegan as Interim CFO
Guegan is currently the company’s Senior VP, Finance, Global Biopharmaceutical Business
Read More
Broken String Biosciences appoints Bruce Eaton as Chairman of the Board
Eaton specialises in strategic planning, organisational leadership and commercial execution
Read More
Fondazione Telethon appoints Graciana Diez-Roux as new Scientific Director
Diez-Roux will lead the Foundation’s scientific activities in rare genetic disease research
Read More
Oriva Therapeutics appoints Agnès Arbat as CEO
Arbat previously held senior roles in women’s health at Oxolife, Bayer and Organon
Read More
Intelligence
Bridging the gap between European brain innovation and real-world policy
Aligning policy and public funding strategies to support brain health across Europe
Read More
Obesity care in the UK – why it can’t improve until it is recognised as a disease
The WHO classified obesity as a chronic disease over twenty years ago – but UK policy has yet to follow
Read More
The next frontier in clinical trials: navigating multi-disease research with GLP-1s
As GLP-1s redefine the treatment landscape for obesity, they are also promising candidates to influence a wide range of disease pathways
Read More
Headline trade and market deals are opening doors to greater patient access
Regulatory changes and tariffs have created a positive climate for investment, innovation and, critically, patient access to therapies
Read More
Men’s health: the gap between awareness and action is where men’s lives are lost
Until the gap between what healthcare systems can offer and how men actually engage with them is closed, outcomes will continue to deteriorate
Read More
The digital age and the advance of AI – pushing communications to new heights
As new comms excellence opportunities abound, staying connected through core messaging remains critical
Read More
Blogs
Latest
Designing Pharma Stands That People Actually Want to Step Onto
June 18, 2026 | Apex Events and Exhibitions|Exhibition Stand Design, Exhibition Stands, events and exhibitions, pharma exhibitions
Exhibition halls are busy environments where delegates move quickly, often with limited time. For pharmaceutical companies, this presents a challenge: how do you create a …
J‑Pharma Co., Ltd. and Uniphar Announce Advancement of Nanvuranlat into Phase 3 Clinical Development Following FDA Alignment and Initial Patient Enrollment
June 17, 2026 | Uniphar|
Strategic partnership enables direct progression to Phase 3, bypassing additional Phase 2 study, as first patients are randomized in global trial TOKYO, Japan and DUBLIN, Ireland — …
Medscape Education Recognized With 2 Spring 2026 Digital Health Awards for Excellence in Clinical Education
June 16, 2026 | Medscape Education|
Medscape Education has been recognized with 2 prestigious accolades at the Spring 2026 Digital Health Awards. The premier digital education platform earned a Gold Award …
New benchmark reveals significant digital maturity gap across UK POM companies’ product-information estates
June 11, 2026 | Genetic Digital|ABPI, Digital, Pharma, Website, compliance, digital estate, digital marketing, emc, pom, prescription only medicines
A new benchmark maps 100 UK prescription medicine companies across five maturity bands and finds a market at very different stages of digital development
The words around health matter
June 4, 2026 | Mednet|Language choices, Making Health Whole, healthcare communications, healthcare innovation, medcomms
The language used in healthcare can influence how people perceive their health, feel about themselves, and engage with treatments. Whole-person communication can help reduce stigma …
Live Webinar | Smarter science, sharper strategy: Expert perspectives from ASCO® 2026
June 18, 2026 | Inizio|
Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.
The solution: Good localisation doesn’t feel translated
June 18, 2026 | Cuttsy + Cuttsy|Engagement, Inclusion, Localisation, Trusted information, clinical trials, translation
Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every …
Good Patient Partnership Guide 2026: Patient Journey Mapping with the Patient Community
June 18, 2026 | Precision AQ|
Patient insight gathering and journey mapping can inform and enhance decision making and initiatives across life sciences. The Good Patient Partnership Guide 2026 brings together …
Healthcare information is becoming easier to access. Trust isn’t.
June 17, 2026 | Cuttsy + Cuttsy|AI, Communications, Digital, health literacy
Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.
It was never reluctance: What ASCO 2026 revealed about clinical trial recruitment
June 17, 2026 | Cuttsy + Cuttsy|ASCO2026, clinical trials
ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.
Build a KOL Community Virtually – Engaging Your Advisors Creatively
October 9, 2025 | Impetus Digital | Community board, HCP Discussion, HCP engagement, HCP forum, Impetus Digital, KOL community board, KOL virtual community, MCL relationships, Pharma community, Pharma tips, Pharma trends, Virtual Engagement, advisor engagement, discussion forum, life science community, peer to peer sharing, virtual advisor